Calumet, Inc. (NASDAQ:CLMT – Get Free Report) has received a consensus rating of “Hold” from the eight brokerages that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokers that have covered the stock in the last year is $20.0417.
A number of brokerages recently issued reports on CLMT. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. The Goldman Sachs Group raised their price objective on shares of Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. TD Cowen lifted their target price on shares of Calumet from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, November 11th. Wall Street Zen lowered Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th.
Read Our Latest Stock Report on CLMT
Institutional Inflows and Outflows
Calumet Price Performance
NASDAQ:CLMT opened at $21.47 on Tuesday. Calumet has a one year low of $7.68 and a one year high of $22.10. The business has a fifty day moving average price of $19.77 and a 200-day moving average price of $18.23. The firm has a market capitalization of $1.86 billion, a price-to-earnings ratio of -49.93 and a beta of 1.23.
Calumet (NASDAQ:CLMT – Get Free Report) last released its quarterly earnings results on Friday, November 7th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.09. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the firm posted ($1.18) EPS. The business’s revenue for the quarter was down 2.0% on a year-over-year basis. On average, equities research analysts expect that Calumet will post -3.02 earnings per share for the current fiscal year.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Featured Articles
- Five stocks we like better than Calumet
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
